Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, US Food and Drug Administration (FDA), will be held online March 3, 2022, to discuss and make recommendations on the selection of strains to be included in the influenza virus vaccines for the 2022-23 influenza season.

See FDA for more information.